What YINGCHI does

YINGCHI (深圳英智科技有限公司 / Shenzhen YINGCHI Technology Co., Ltd.) is a Shenzhen-headquartered Chinese medical device company founded in 2012 and operating as a wholly-owned subsidiary of Hanxiang Brain Science (瀚翔脑科学). The company specializes in non-invasive brain and neurological disease diagnosis and treatment technology, designing and distributing neuroimaging and neuromodulation equipment — EEG (electroencephalography), TMS (transcranial magnetic stimulation), fNIRS (functional near-infrared spectroscopy), and brain-computer interface hardware — to hospitals and clinical institutions. With roughly 15 employees, YINGCHI operates an enterprise field sales motion targeting clinical buyers in psychiatry, neurology, rehabilitation, pediatrics, sleep, epilepsy, and coma awakening centers across China.

The company's product portfolio centers on EEG systems (notably the BE PLUS PRO with 32KHz sampling rate, 24-bit ADC precision, and AC/DC channel switching — technology localized from Italian firm EB Neuro), a complete TMS product family (E/M/S/X series) plus FDA-approved Deep TMS systems for major depressive disorder and OCD, fNIRS devices for cerebral hemoglobin monitoring, multi-channel transcranial electrical stimulators, and ancillary products such as TMS 3D navigation systems, portable bedside TMS, and pelvic floor magnetic stimulators. The core technical differentiator is closed-loop TMS-EEG integration, enabling real-time EEG monitoring combined with magnetic stimulation, alongside multi-modal integration packages (TMS-EEG, TMS-fNIRS, TMS-fMRI) packaged into department-level clinical solutions.

YINGCHI monetizes primarily through direct-to-hospital hardware sales, supplemented by clinical configuration, technical support, and clinician training services. The company invests in demand generation through its Naoke China (脑客中国) academic content platform, participation in national conferences such as the 2026 National Brain-Computer Interface Technology and Industry Integration Innovation Conference, and clinician training programs. It holds FDA certification for its TMS device for treatment of major depressive disorder, providing a regulatory pathway to international markets, and its TMS-EEG closed-loop device won the 2026 Top 10 Brain-Computer Interface Innovation Products award.

Name

YINGCHI

Legal name

深圳英智科技有限公司

Website

https://yingchitech.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

YINGCHI is a Shenzhen-based medical device company and wholly-owned subsidiary of Hanxiang Brain Science, developing non-invasive brain diagnostic and neuromodulation equipment (EEG, TMS, fNIRS, brain-computer interfaces) sold to hospitals across psychiatry, neurology, rehabilitation, and related clinical departments in China.

Ownership category

akta.pro rank

Product category

Neuromodulation and Neuroimaging Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

Keywords

• Non-invasive neuromodulation devices
• Transcranial magnetic stimulation
• Electroencephalography equipment
• Functional brain imaging
• Brain-computer interface technology

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

1. Medical Equipment Sales: Sale of neuroimaging and neuromodulation devices including EEG systems, TMS devices (E/M/S/X series), deep TMS systems, fNIRS equipment, and brain-computer interface hardware to hospitals and clinical institutions.
2. Clinical Solutions & Support Services: Integrated clinical solutions for specific departments (psychiatry, neurology, rehabilitation, sleep centers) including product configuration, technical support, and training services for medical institutions.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

YINGCHI (Shenzhen Yingchi Technology Co., Ltd.) is a medical device company that develops, manufactures, and sells non-invasive neuroimaging and neuromodulation equipment — including EEG systems, transcranial magnetic stimulation (TMS) devices, deep TMS (dTMS) systems, fNIRS brain imaging devices, multi-channel transcranial electrical stimulators, and brain-computer interface hardware — for hospitals and clinical institutions across psychiatry, neurology, rehabilitation, sleep, and epilepsy departments. The company also provides integrated clinical solutions, configuration, training, and technical support services.

Product overview

YINGCHI (英智科技) offers a comprehensive portfolio of non-invasive neurological diagnostic and treatment equipment as a subsidiary of Hanxiang Brain Science. The core product line includes BE PLUS PRO EEG systems for neurophysiological assessment, Transcranial Magnetic Stimulation (TMS) devices in E/M/S/X series plus deep TMS for depression and OCD treatment, and fNIRS devices for functional brain imaging. The ecosystem integrates multi-modal solutions combining EEG/TMS/fNIRS for clinical diagnosis and research applications across psychiatry, neurology, rehabilitation, pediatrics, sleep centers, and epilepsy centers. Research-oriented products include TMS-EEG systems, 3D navigation for precise targeting, and multi-channel electrical stimulation devices.

Differentiator

Problem solved

Functional benefit

Products and services

• BE PLUS PRO EEG System Full-scene EEG system with 32KHz ultra-high sampling rate, 24-bit ADC precision, AC/DC channel switching, and up to 200 channels with USB/LAN/WIFI transmission. Technology sourced from Italian EB Neuro with domestic localization. For hospitals and clinical institutions performing neurophysiological assessment.
• Transcranial Magnetic Stimulation (TMS) Device Non-invasive magnetic stimulation device for brain nerve regulation, available in E, M, S, and X series with varying specifications for clinical and research applications. For hospitals and clinical research institutions.
• Deep Transcranial Magnetic Stimulation (dTMS) System Deep brain magnetic stimulation system using H-coil technology for targeted intervention of deep brain regions including the ACC. FDA approved for treatment of depression and OCD. For psychiatric and neurological clinical institutions.
• Functional Near-Infrared Spectroscopy (fNIRS) Device Near-infrared brain functional imaging device for monitoring cerebral oxygenated and deoxygenated hemoglobin changes in brain tissue. For clinical research and brain function assessment.
• Multi-channel Transcranial Electrical Stimulation Device Multi-channel transcranial electrical stimulation device for non-invasive brain modulation. For clinical research and brain function modulation applications.
• Research TMS Systems Research-oriented TMS systems including TMS-EEG, CED-compatible, double-blind, full-featured, single-pulse paired, and magnetic-electric paired stimulation kits. For clinical research institutions and neuroscience research labs.
• TMS 3D Navigation System 3D navigation system for precise TMS targeting using MRI-guided neuronavigation. For clinical institutions requiring precise TMS targeting.
• Pelvic Floor Magnetic Stimulator Magnetic stimulation device for pelvic floor rehabilitation. For hospitals and rehabilitation centers.
• Portable Bedside TMS Device Portable bedside TMS device for bedside neurological intervention. For hospitals and clinical institutions requiring bedside neuromodulation.
• EEG/Event-Related Potential Analyzer Combined EEG and event-related potential analysis system for neurophysiological assessment. For hospitals and clinical research institutions.
• Wireless Dry Electrode EEG System Wireless EEG system using dry electrodes for convenient and flexible brain wave monitoring. For clinical and research applications requiring flexible EEG monitoring.
• High-Density Long-Term EEG System High-density EEG system for extended monitoring with comprehensive channel coverage. For hospitals and clinical institutions requiring long-term EEG monitoring.
• Ambulatory EEG System Portable EEG system for ambulatory monitoring outside clinical settings. For clinical and research applications requiring portable monitoring.

Quantifiable outcome

• FDA certified for TMS treatment of major depressive disorder
• +1 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• 瀚翔脑科学 (Hanxiang Brain Science)coreStrategic or Co-development Partner瀚翔脑科学 is the parent company of 深圳英智科技有限公司 (YINGCHI). YINGCHI operates as a wholly-owned subsidiary specializing in precision non-invasive diagnosis and treatment technology for brain and neurological diseases.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Neuronetics: US-listed developer of NeuroStar TMS, the first FDA-cleared TMS system for major depressive disorder. Direct competitor in the FDA-approved depression TMS market YINGCHI is now entering.
• MagVenture: Danish manufacturer of TMS systems with FDA-cleared and CE-marked products for clinical depression and research applications. Direct competitor in TMS hardware globally.
• Brainsway: Israeli medical device company commercializing deep TMS (dTMS) systems with FDA clearance for depression, OCD, and smoking cessation. Closest direct competitor to YINGCHI's deep TMS franchise.
• Compumedics: Australian developer of EEG, polysomnography, and neurodiagnostic systems for clinical and research use. Direct competitor to YINGCHI's EEG and sleep center offerings.
• Magstim: UK-based manufacturer of TMS systems widely used in clinical and research settings globally. Direct peer in TMS hardware, including neuroscience research-grade devices.
• ANT Neuro: Dutch manufacturer of high-density EEG systems, TMS-EEG integration, and fNIRS products for clinical neuroscience research. Direct peer in multi-modal EEG/TMS research equipment.
• WAVELENGTH ENTERPRISES: US-based developer of transcranial photobiomodulation (tPBM) and adjunct neuromodulation devices for depression and neurological conditions. Emerging adjacent peer in the neuromodulation category YINGCHI serves.

Broad incumbents

• Natus Medical: Established US neurodiagnostic and newborn care equipment company offering EEG, EMG, and ICU monitoring systems at scale. Broad incumbent competing with YINGCHI's EEG/EP portfolio in hospital channels.

Emerging players

• BrainCo: Chinese brain-computer interface company developing EEG-based prosthetics, education, and consumer focus products. Domestic emerging peer with overlapping BCI and EEG ambitions within China.

Others

• EB Neuro: Italian century-old neurophysiology equipment manufacturer; YINGCHI's BE PLUS PRO EEG inherits core technology from EB Neuro. Partner/competitor with overlapping EEG product lines in European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/shenzhen-yingchi-technology-co-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YINGCHI